Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane progesterone receptor delta (mPRδ) is a member of the membrane progesterone receptor (mPR) family, also known as progestin and adipoQ receptor family members (PAQRs). It mediates rapid, non-genomic actions of progesterone. mPRδ is encoded by the PAQR6 gene and is primarily located at the plasma membrane. Structurally, it is predicted to have seven transmembrane domains, similar to G protein-coupled receptors (GPCRs). Upon activation by progesterone, mPRδ couples to G proteins, leading to modulation of second messenger systems such as cAMP levels. It is widely distributed across vertebrate tissues and participates in diverse functions including reproductive processes, neuroprotection, behavior regulation, and immune function.
Agonist; binds to mPRδ and activates G protein signaling pathways, leading to rapid non-genomic effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane Progesterone Receptor Delta (mPRδ).